泪腺功能再生以维护眼表健康
干眼是全球最常见的疾病之一,水液性泪液缺乏是主要原因,而泪液主要来自泪腺。泪腺萎缩或损伤可导致眼表感染、角膜溃疡和角化等严重疾病,现有疗法无法完全恢复泪腺功能。本综述总结以泪腺为治疗靶点的当前认识,以及基于泪腺细胞治疗严重干眼的最新进展。
要点
- 泪腺分泌水液性泪液,对维持眼表健康至关重要。
- 泪腺萎缩或损伤可导致严重眼表疾病,现有疗法无法完全恢复功能。
- 动物模型中器官移植疗法可直接或间接恢复泪腺功能。
核心结论
- 泪腺是干眼治疗的重要靶点,基于泪腺细胞的疗法有望治疗严重干眼。
研究设计与样本
- 综述,总结泪腺作为干眼治疗靶点的当前认识及泪腺细胞治疗进展。
主要发现
- 严重炎症时泪腺组织结构被破坏,伤口愈合过程中被瘢痕替代,导致泪腺功能障碍。
- 利用泪腺功能障碍动物模型,许多研究者研究了泪腺炎症的分子机制。
- 要恢复泪腺功能,必须在微环境中恢复泪腺腺泡。
- 动物模型报道器官移植疗法可直接或间接恢复泪腺功能。
临床怎么用
- 理解泪腺分子生物学和炎症过程,有助于开发更明确的干眼疗法。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Dry eye is a multifactorial disease that is one of the most common diseases worldwide. A major cause of dry eye is the deficiency of aqueous tears, which are mainly secreted from the lacrimal gland. The lacrimal gland plays an important role in maintaining the health of the ocular surface and protecting it from environmental exposure. Dry eye can lead to ocular irritation and discomfort, as well as severe ocular surface diseases (e.g., ocular infections, corneal ulcerations, and ocular surface keratinization). These severe diseases can be induced by an atrophied or injured lacrimal gland; current therapies cannot completely restore the function of lacrimal gland. To develop more definitive therapies, it is important to understand lacrimal gland biology at the molecular level, as well as inflammatory processes affecting the function of the gland. During severe inflammation, the tissue structure of the lacrimal gland is destroyed; it is replaced by scar formation during wound healing, which leads to lacrimal gland dysfunction. Using an animal model of lacrimal gland dysfunction, many investigators have studied molecular mechanisms of inflammation in the lacrimal gland. To restore lacrimal gland function, the lacrimal acini must be restored in their niche. Notably, organ transplantation therapies have been reported to restore lacrimal gland function, directly or indirectly, in animal models. In this review, we describe the current understanding of the lacrimal gland as the therapeutic target for dry eye diseases, as well as recent advances in the field of lacrimal gland cell-based therapy to treat severe dry eye diseases.
引用
- Kawakita T. Regeneration of Lacrimal Gland Function to Maintain the Health of the Ocular Surface. Invest Ophthalmol Vis Sci. 2018. PMID: 30481823. doi:10.1167/iovs.17-23576
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。